Enterovirus Infections  >>  TMC647055  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TMC647055 / J&J
NCT01202825: TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients

Completed
1
72
Europe
TMC647055, Placebo, TMC435
Tibotec Pharmaceuticals, Ireland
Hepatitis C
11/11
11/11

Download Options